Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03325855 · ClinicalTrials.gov registry record

Fecal Microbiota Transplant National Registry

A clinical trial of Gut Microbiome and Clostridium Difficile Infection, sponsored by American Gastroenterological Association.

Recruiting
Registry status
4,000
Enrollment target
20
Study locations

NCT03325855 is a study of Gut Microbiome and Clostridium Difficile Infection that is actively recruiting participants, run by American Gastroenterological Association. The registered enrollment target is 4,000 participants, above the 86-participant average among 22 other Gut Microbiome trials with a reported enrollment target (4551% higher). The trial reports 20 study locations across 8 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03325855, a study of Gut Microbiome and Clostridium Difficile Infection, is actively recruiting participants, sponsored by American Gastroenterological Association.

RECRUITING
Registry status
4,000 participants
Enrollment target
20
Study locations

Study Summary

A national data registry of patients receiving fecal microbiota transplantation (FMT) or other gut-related-microbiota products designed to prospectively assess short and long-term safety and effectiveness

Conditions Studied

Gut Microbiome Clostridium Difficile Infection Fecal Microbiota Transplantation

Interventions

  • OTHER None - Observational

Study Locations (20)

California

  • Children's Hospital of Los Angeles - Los Angeles
  • University of California - Los Angeles
  • Stanford University - Redwood City
  • Sutter Roseville Medical Center - Roseville
  • University of California San Francisco - San Francisco
  • Ventura Clinical Trials - Ventura

Illinois

  • The University of Chicago - Chicago
  • University of Chicago School of Medicine - Chicago
  • NorthShore University Health System - Evanston
  • Loyola University Medical Center - Maywood
  • Loyola University of Chicago/ Loyola University Medical Center - Maywood
  • Carle Foundation Hospital - Urbana

Florida

  • Best Quality Research, Inc. - Hialeah
  • University of Miami, Miller School of Medicine - Miami
  • GI Pros - Naples

Arizona

  • Phoenix Children's Hospital - Phoenix

Connecticut

  • Yale New Haven Hospital - Hamden

District of Columbia

  • MedStar Georgetown University Hospital - Georgetown

Georgia

  • Emory University School of Medicine - Atlanta

Indiana

  • Indiana University School of Medicine - Indianapolis

Trial Details

FieldValue
Enrollment Target 4,000 participants
Start Date 2017-09-20
Est. Completion 2027-08

Sponsor

American Gastroenterological Association

3 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03325855

The ClinicalTrials.gov registry entry for NCT03325855 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 4,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 86-participant average among 22 other Gut Microbiome trials with a reported enrollment target (4551% higher). The listed sponsor is American Gastroenterological Association, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Gut Microbiome appearing as the primary indexed condition, and to 1 intervention - of which None - Observational is the first listed.

NCT03325855 reports 20 study locations spanning 8 distinct geographic areas - top geographies include California, Illinois, Florida.

Frequently Asked Questions

What is clinical trial NCT03325855 about?

NCT03325855 is a clinical study titled "Fecal Microbiota Transplant National Registry". A national data registry of patients receiving fecal microbiota transplantation (FMT) or other gut-related-microbiota products designed to prospectively assess short and long-term safety and effectiveness

What is the current status of trial NCT03325855?

This trial is currently recruiting. The enrollment target is 4,000 participants. The study started on 2017-09-20. Estimated completion is 2027-08.

What conditions does trial NCT03325855 study?

This clinical trial studies the following conditions: Gut Microbiome, Clostridium Difficile Infection, Fecal Microbiota Transplantation.

What interventions are being tested in trial NCT03325855?

The interventions under investigation include: None - Observational (OTHER).

Who is sponsoring clinical trial NCT03325855?

This trial is sponsored by American Gastroenterological Association, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03325855 being conducted?

This trial has 20 study locations across Arizona, California, Connecticut, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Gut Microbiome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Gut Microbiome

All registered trials for this condition

Clostridium Difficile Infection

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.